These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38576148)

  • 61. Anti-Inflammatory Dose Doxycycline Plus Adapalene 0.3% and Benzoyl Peroxide 2.5% Gel for Severe Acne.
    Kircik LH
    J Drugs Dermatol; 2019 Sep; 18(9):924-927. PubMed ID: 31524349
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
    Tanghetti E
    Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.
    Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Kerrouche N; Tan J
    Am J Clin Dermatol; 2018 Apr; 19(2):275-286. PubMed ID: 29549588
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions.
    Feldman SR; Tan J; Poulin Y; Dirschka T; Kerrouche N; Manna V
    J Am Acad Dermatol; 2011 Jun; 64(6):1085-91. PubMed ID: 21439678
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A split-faced, observer-blinded comparison study of topical adapalene/benzoyl peroxide and adapalene in the treatment of Asian acne patients.
    Kim WJ; Park JM; Ko HC; Kim BS; Kim MB; Song M
    J Drugs Dermatol; 2013 Feb; 12(2):149-51. PubMed ID: 23377384
    [No Abstract]   [Full Text] [Related]  

  • 66. Epiduo (adapalene 0.1% and benzoyl peroxide 2.5%) approval in children 9 years and older.
    Scheinfeld N
    Skinmed; 2013; 11(5):295-6. PubMed ID: 24340470
    [No Abstract]   [Full Text] [Related]  

  • 67. Recent advances in the use of adapalene 0.1%/benzoyl peroxide 2.5% to treat patients with moderate to severe acne.
    Leyden J
    J Dermatolog Treat; 2016; 27 Suppl 1():S4-13. PubMed ID: 26947815
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.
    Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC
    Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris.
    Zouboulis CC; Fischer TC; Wohlrab J; Barnard J; Alió AB
    Cutis; 2009 Oct; 84(4):223-9. PubMed ID: 19911678
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adapalene: a review of its use in the treatment of acne vulgaris.
    Waugh J; Noble S; Scott LJ
    Drugs; 2004; 64(13):1465-78. PubMed ID: 15212561
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris.
    Zeichner JA; Wong V; Linkner RV; Haddican M
    J Drugs Dermatol; 2013 Mar; 12(3):277-82. PubMed ID: 23545909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis.
    Stuart B; Maund E; Wilcox C; Sridharan K; Sivaramakrishnan G; Regas C; Newell D; Soulsby I; Tang KF; Finlay AY; Bucher HC; Little P; Layton AM; Santer M
    Br J Dermatol; 2021 Sep; 185(3):512-525. PubMed ID: 33825196
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combination topical therapy in the treatment of acne.
    Del Rosso JQ
    Cutis; 2006 Aug; 78(2 Suppl 1):5-12. PubMed ID: 17966494
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD; Potts A; Alió Saenz AB;
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
    Ioannides D; Rigopoulos D; Katsambas A
    Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
    Thiboutot D; Eichenfield L; Shalita A; Del Rosso JQ; Swinyer L; Tanghetti E; Tschen E; Parr L
    Cutis; 2009 Jul; 84(1):48-55. PubMed ID: 19743725
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide/0.1% adapalene in the acne treatment: a randomized, split-face, open-label, single-center study.
    Zheng Y; Yin S; Xia Y; Chen J; Ye C; Zeng Q; Lai W
    Cutan Ocul Toxicol; 2019 Mar; 38(1):48-54. PubMed ID: 30173582
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
    Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D
    Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.